MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijmmb.2026.101198

Медицинская библиотека · Indian journal of medical microbiology · 2026

Nontuberculous mycobacteria in Mumbai: Species distribution and susceptibility.

Irfana Mohammed, Agrawal Umang, Shah Nisarg, Shetty Siddhant, Ajbani Kanchan, Salvi Asmita, Basu Shaoli, Shetty Anjali, Rodrigues Camilla, Soman Rajeev, Sunavala Ayesha

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Non-tuberculous mycobacteria (NTM) infections are globally prevalent, yet species distribution and antibiotic susceptibility vary considerably across regions. In India, limited epidemiological data have led to treatment practices based largely on western guidelines.

AIM: This retrospective observational study aims to generate data on the distribution of NTM species and species-specific antibiotic susceptibility patterns at our centre, and to compare these findings with both local and international data to improve treatment outcomes.

MATERIAL AND

METHODS

A 9-year retrospective observational study was conducted at our institute in Mumbai, India, from June 2014 to June 2023. A total of 891 NTM isolates were analyzed-728 (81.7%) rapidly growing mycobacteria (RGM) and 163 (18.3%) slow-growing mycobacteria (SGM). Speciation was performed for 68.2% of RGM isolates, and antimicrobial susceptibility testing was done using standardized protocols.

RESULTS

Among RGM, M. abscessus, M. fortuitum, and M. chelonae were predominant. High susceptibility rates were observed to amikacin (100%) and linezolid (M. abscessus 100%, M. fortuitum 100%, M. chelonae 95%). Clarithromycin susceptibility was 90% for M. abscessus, 78% for M. fortuitum, and 90% for M. chelonae. M. fortuitum showed significantly higher susceptibility to quinolones (90% vs <20% for other species). Susceptibility to clarithromycin, linezolid, imipenem, and tobramycin differed notably from western data.

CONCLUSION

RGM susceptibility patterns vary significantly between and within countries, underscoring the need for regional antimicrobial surveillance and India-specific treatment guidelines.

CAVEATS: Speciation was done for 68.2% of RGM isolates, and inducible macrolide resistance testing was included only after 2017. Clinical correlation was unavailable for a few isolates; hence, colonization could not be ruled out for some respiratory samples. SGM susceptibility data was not available.

Для цитирования: Irfana Mohammed, Agrawal Umang, Shah Nisarg, Shetty Siddhant, Ajbani Kanchan, Salvi Asmita, Basu Shaoli, Shetty Anjali, Rodrigues Camilla, Soman Rajeev, Sunavala Ayesha. Nontuberculous mycobacteria in Mumbai: Species distribution and susceptibility.. Indian journal of medical microbiology. 2026. DOI: 10.1016/j.ijmmb.2026.101198.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.